Your browser doesn't support javascript.
loading
High-dose sequential chemotherapy (HDS) versus PEB chemotherapy as first-line treatment of patients with poor prognosis germ-cell tumors: mature results of an Italian randomized phase II study.
Necchi, A; Mariani, L; Di Nicola, M; Lo Vullo, S; Nicolai, N; Giannatempo, P; Raggi, D; Farè, E; Magni, M; Piva, L; Matteucci, P; Catanzaro, M; Biasoni, D; Torelli, T; Stagni, S; Bengala, C; Barone, C; Schiavetto, I; Siena, S; Carlo-Stella, C; Pizzocaro, G; Salvioni, R; Gianni, A M.
Afiliação
  • Necchi A; Department of Medical Oncology. Electronic address: andrea.necchi@istitutotumori.mi.it.
  • Mariani L; Clinical Epidemiology and Trials Organization Unit.
  • Di Nicola M; Department of Medical Oncology.
  • Lo Vullo S; Clinical Epidemiology and Trials Organization Unit.
  • Nicolai N; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Giannatempo P; Department of Medical Oncology.
  • Raggi D; Department of Medical Oncology.
  • Farè E; Department of Medical Oncology.
  • Magni M; Department of Medical Oncology.
  • Piva L; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Matteucci P; Department of Medical Oncology.
  • Catanzaro M; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Biasoni D; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Torelli T; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Stagni S; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Bengala C; Department of Medical Oncology, Ospedale Misericordia, Grosseto.
  • Barone C; Department of Medical Oncology, Oncologia Medica ASL TO5 Ospedale di Carmagnola, Turin.
  • Schiavetto I; Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan.
  • Siena S; Niguarda Cancer Center, Ospedale Niguarda Ca' Granda, Milan.
  • Carlo-Stella C; Department of Oncology and Hematology, Humanitas Cancer Center, Humanitas Clinical and Research Center, Rozzano; Department of Medical Biotechnology and Translational Medicine.
  • Pizzocaro G; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Salvioni R; Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.
  • Gianni AM; Department of Medical Oncology; Department of Pathophysiology and Transplantation, University of Milano, Milan, Italy.
Ann Oncol ; 26(1): 167-172, 2015 Jan.
Article em En | MEDLINE | ID: mdl-25344361
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Testiculares / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Embrionárias de Células Germinativas Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article